Thrombotic thrombocytopenic purpura induced by trimethoprim‐sulfamethoxazole in a Jehovah's witness
Open Access
- 31 January 2007
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 82 (7) , 679-681
Abstract
We report a case of Thrombotic Thrombocytopenic Purpura occurring as an allergic response to trimethoprim‐sulfamethoxazole therapy (Bactrim™, Septra®) in a Jehovah's Witness patient. The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim‐sulfamethoxazole. Other symptoms of drug hypersensitivity included nausea, vomiting, urticarial rash, and leukopenia. Because of her religious faith, the patient was supported without plasma therapy with use of intravenous immunoglobulin, steroids, rituximab, and erythropoietin. Am. J. Hematol., 2007.Keywords
This publication has 9 references indexed in Scilit:
- The molecular biology of thrombotic microangiopathyKidney International, 2006
- Drug-Induced Thrombotic MicroangiopathySeminars in Thrombosis and Hemostasis, 2005
- The Oklahoma thrombotic thrombocytopenic Purpura-Hemolytic uremic syndrome (TTP-HUS) registry: a community perspective of patients with clinically diagnosed TTP-HUSSeminars in Hematology, 2004
- Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah’s WitnessTransfusion and Apheresis Science, 2003
- Drug-induced acute interstitial nephritis and vasculitis or vasculary rejection in renal allografts.American Journal of Kidney Diseases, 2001
- Drug-Induced Acute Interstitial Nephritis and Vasculitis or Vasculary Rejection in Renal AllograftsAmerican Journal of Kidney Diseases, 2001
- Management of a Jehovah's Witness with thrombotic thrombocytopaenic purpura/haemolytic uraemic syndromeJournal of Clinical Apheresis, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Thrombotic Thrombocytopenic Purpura: Report of a Case with a Possible Response to High-Dose Intravenous Gamma GlobulinActa Haematologica, 1989